Cargando…
A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect
Cancer Targeting Gene-Viro-Therapy (CTGVT) is a promising cancer therapeutical strategy that strengthens the anti-tumour effect of oncolytic virus by expressing inserted foreign anti-tumour genes. In this work, we constructed a novel adenoviral vector controlled by the tumour-specific survivin promo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823082/ https://www.ncbi.nlm.nih.gov/pubmed/21794078 http://dx.doi.org/10.1111/j.1582-4934.2011.01396.x |